Biblio Discovery — Demo Discovery Service

5 results for "Robin Demuynck"

Showing 1–5 · 0.19 seconds · RSS

  1. Journal Article

    Ferroptosis: friend or foe in cancer immunotherapy?

    Robin Demuynck; Iuliia Efimova; Elena Catanzaro et al.

    OncoImmunology, Vol. 12 No. 1 · 2023 · English · DOAJ Scopus

    Ferroptosis has gained interest due to it immunogenicity and the higher sensitivity of cancer cells to it. However, it was recently shown that ferroptosis in tumor-associated neutrophils leads to immunosuppression and negatively impacts therapy. Here, we discuss the potential implications of the…

  2. Journal Article Full text

    A 3D Cell Death Assay to Quantitatively Determine Ferroptosis in Spheroids

    Robin Demuynck; Iuliia Efimova; Abraham Lin et al.

    Cells, Vol. 9 No. 3 · 2020 · English · DOAJ Scopus

    The failure of drug efficacy in clinical trials remains a big issue in cancer research. This is largely due to the limitations of two-dimensional (2D) cell cultures, the most used tool in drug screening. Nowadays, three-dimensional (3D) cultures, including spheroids, are acknowledged to be a better…

  3. Journal Article Full text

    In Vitro Veritas: From 2D Cultures to Organ-on-a-Chip Models to Study Immunogenic Cell Death in the Tumor Microenvironment

    Dmitri V. Krysko; Robin Demuynck; Iuliia Efimova et al.

    Cells, Vol. 11 No. 22 · 2022 · English · DOAJ Scopus

    Immunogenic cell death (ICD) is a functionally unique form of cell death that promotes a T-cell-dependent anti-tumor immune response specific to antigens originating from dying cancer cells. Many anticancer agents and strategies induce ICD, but despite their robust effects in vitro and in vivo on…

  4. Journal Article

    CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunity

    Faye Naessens; Robin Demuynck; Olga Vershinina et al.

    Frontiers in Immunology, Vol. 15 · 2024 · English · DOAJ Scopus

    IntroductionImmunogenic cell death (ICD) has emerged as a novel option for cancer immunotherapy. The key determinants of ICD encompass antigenicity (the presence of antigens) and adjuvanticity, which involves the release of damage-associated molecular patterns (DAMPs) and various cytokines and…

  5. Journal Article

    Ferroptosis-armed dendritic cell vaccines for glioma immunotherapy

    Mariia Saviuk; Victoria D. Turubanova; Sara De Brée et al.

    Nature Communications, Vol. 17 No. 1 · 2026 · English · DOAJ Scopus

    Abstract The type of cell death has proven to play a crucial role in cancer immunotherapy efficacy. Immunogenic cell death (ICD) enhances tumor adjuvanticity and antigenicity by releasing danger signals and altering the immune peptidome. The immunogenicity of ferroptosis, an iron-dependent form of…